JPRN-UMIN000042016尚未招募未知
Examination of equivalence between biosimilar and original in insulin lispro - Examination of equivalence between biosimilar and original in insulin lispro
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with severe ketosis, diabetic coma or precoma 2. Patients with severe infections, before and after surgery, and with serious external injury 3. Patients with severe renal dysfunction or end-stage renal disease on dialysis 4. Patients that the attending physician deems inappropriate for this study for other reasons
研究者
相似试验
进行中（未招募）
1 期
Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteersCTIS2023-509752-34-00CCDRD Cooperative Clinical Drug Research and Development AG28
招募中
不适用
Bioequivalency study of two different Metformin formulationsIRCT20111107008022N7Reihaneh Pharmaceutical Company24
尚未招募
Unknown
Bioequivalence study of two different Ciprofloxacin formulationsIRCT20111107008022N13Zagrous Darou Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of two different Fenofibrate formulationsIRCT20111107008022N10Aviccena Pharmaceutical Company24
招募中
不适用
Bioequivalency study of two different Pantoprazole formulationsHealth volunteers.IRCT20111107008022N8Exir Pharmaceutical Company24